Aim Trials, Llc

Plano, Texas 75093

9 studies enrolling now · 26 studies all time

What they study most

Acute Migraine, Acute Treatment of Migraine, Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Bipolar Disorder, COVID-19, Depression, Depressive Disorder, Major, Generalized Anxiety Disorder, Gout, Gout Flare, Hyperuricemia

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder — Recruiting now
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder — Recruiting now
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) — Recruiting now
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD — Recruiting now
• Psilocybin for Major Depressive Disorder (MDD) — Running, not enrolling
• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder — Stopped early
• Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder — Completed
• A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• Real World Effectiveness of Eptinezumab in Participants With Migraine — Stopped early
• A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) — Completed
• MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age — Completed
• Vortioxetine to Prevent Return of Symptoms in Children With Depression — Stopped early
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) — Completed
• A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants — Completed
• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder — Stopped early
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma — Stopped early